Results of Equity Issue

RNS Number : 1514Q

The MedicX Fund Limited

03 April 2009

 



THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN

For Immediate Release	03 April 2009

MedicX Fund Limited

('MedicX Fund', 'the Fund' or 'the Company')

Results of Equity Issue

MedicX Fund Limited, (LSE: MXF) (the 'Company'), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, wishes to announce the results of its placing and offer for subscription of new ordinary shares (the 'New Ordinary Shares').

The Company has raised £15 million through the placing and offer for subscription. 21,750,000 New Ordinary Shares will be issued at a price of 69 pence per share, of which 5,833,450 New Ordinary Shares will be issued pursuant to the offer for subscription and 15,916,550 New Ordinary Shares will be issued pursuant to the placing.

Application has been made for the New Ordinary Shares to be admitted to the Official List of the UK Listing Authority and to trading on the main market for listed securities of the London Stock Exchange plc. Dealings in the New Ordinary Shares are expected to commence on 08 April 2009.

David Staples, the Chairman of the Company, has subscribed under the offer for subscription for 20,000 New Ordinary Shares at a price of 69 pence per share.

-Ends-

For further information please contact:

MedicX Fund                                                          [phone]

David Staples, Chairman

MedicX Group                                                         [phone]

Keith Maddin, Chairman

Mike Adams, Managing Director

Buchanan Communications                                        [phone]

Charles Ryland/Mary-Jane Johnson/Miranda Higham

Collins Stewart Europe Limited

Robbie Robertson/Andrew Zychowski/Helen Goldsmith     [phone]

Important Information

This announcement does not constitute an offer of, or the solicitation of an offer to buy or subscribe for, any securities of the Company to any person in any jurisdiction to whom or in which such offer or solicitation is unlawful and, in particular, is not for release, publication or distribution in or into the United States, Australia, Canada or Japan. The Offer for Subscription and the Placing of the New Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended or under the applicable securities laws of Australia, Canada or Japan. Subject to certain exceptions, the New Ordinary Shares may not be offered or sold in Australia, Canada, Japan or the United States.

The contents of this announcement have been prepared by and are the sole responsibility of the Company. Collins Stewart Europe Limited ('Collins Stewart') is acting exclusively for the Company and no one else in connection with the equity issue. Collins Stewart does not regard any other person (whether or not a recipient of this announcement) as its client in relation to the equity issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the content of this announcement or any transaction or other matter referred to herein.

 

END

 

 

ROICKNKDABKDBQK